Victor de Lédinghen

1994–2025 年に発表

別表記
Victor De Ledinghen · Victor de Ledinghen · Victor De Lédinghen
206
論文数
41,583
被引用数
103
h 指数
198
i10 指数

被引用数

Victor de Lédinghen の年別被引用数1967 年: 被引用 1 件1997 年: 被引用 1 件1998 年: 被引用 2 件2000 年: 被引用 1 件2001 年: 被引用 2 件2002 年: 被引用 5 件2003 年: 被引用 11 件2004 年: 被引用 17 件2005 年: 被引用 32 件2006 年: 被引用 97 件2007 年: 被引用 145 件2008 年: 被引用 276 件2009 年: 被引用 189 件2010 年: 被引用 339 件2011 年: 被引用 275 件2012 年: 被引用 282 件2013 年: 被引用 305 件2014 年: 被引用 376 件2015 年: 被引用 403 件2016 年: 被引用 363 件2017 年: 被引用 425 件2018 年: 被引用 420 件2019 年: 被引用 1,568 件2020 年: 被引用 1,486 件2021 年: 被引用 1,473 件2022 年: 被引用 1,245 件2023 年: 被引用 983 件2024 年: 被引用 2,019 件2025 年: 被引用 923 件2026 年: 被引用 47 件1968〜1996 年は被引用が無いため表示していません1999 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,478 件、この内訳の 16.5%中国: 引用元論文 1,301 件、この内訳の 8.7%イタリア: 引用元論文 995 件、この内訳の 6.6%フランス: 引用元論文 939 件、この内訳の 6.3%イギリス: 引用元論文 891 件、この内訳の 6%ドイツ: 引用元論文 736 件、この内訳の 4.9%スペイン: 引用元論文 595 件、この内訳の 4%日本: 引用元論文 508 件、この内訳の 3.4%カナダ: 引用元論文 500 件、この内訳の 3.3%オーストラリア: 引用元論文 410 件、この内訳の 2.7%韓国: 引用元論文 370 件、この内訳の 2.5%スイス: 引用元論文 310 件、この内訳の 2.1%
0%16.5%その他 33%

分野

  • Medicine91.6%
  • Biochemistry, Genetics and Molecular Biology4.6%
  • Nursing0.7%
  • Immunology and Microbiology0.6%
  • Engineering0.5%
  • Neuroscience0.5%
  • その他1.5%

トピック

  • Liver Disease Diagnosis and Treatment23.8%
  • Liver Disease and Transplantation9.4%
  • Hepatitis C virus research8.6%
  • Hepatitis B Virus Studies4.6%
  • Liver Diseases and Immunity4.1%
  • Hepatocellular Carcinoma Treatment and Prognosis3.8%
  • その他45.7%

共著者

全論文

検索で開く
  1. Advancing the global public health agenda for NAFLD: a consensus statement

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yusuf Yılmaz, Zobair M. Younossi, Shira Zelber‐Sagi, Fredrik Åberg, Leon A. Adams, Maryam Salem Al Khatry, Khalid Al Naamani, Omar Alfaro Murillo, Alina M. Allen, Faisal Abdullatif Alnaser, Saleh A. Alqahtani, Khalid Alswat, Domenico Alvaro, Raúl J. Andrade, Marco Arrese, Yaw Asante Awuku, Motala Ayesha, Oidov Baatarkhuu, Shokhista Bakieva, Rita Basu, Ramón Bataller, Shahinaz Bedri, Emanuele Bosi, Marc Bourlière, Radan Brůha, Elisabetta Bugianesi, Patrizia Burra, Marı́a Buti, Christopher D. Byrne, José Luís Calleja, Patrizia Carrieri, Flloyd Carter, Marlén Ivón Castellanos Fernández, Gabriela Castillo-Lopez, Graciela Castro‐Narro, Henry Lik‐Yuen Chan, Wah‐Kheong Chan, Yoosoo Chang, Massimo Colombo, Kirsten J. Coppell, Kathleen E. Corey, Antonio Craxı̀, Donna R. Cryer, Anuradha Supun Dassanayake, Antonieta de Ascenção Soares Martins, Victor de Lédinghen, Stefano DelPrato, Sandro Demaio, Hailemichael Desalegn, John Dillon, Ajay Duseja, Prabhakaran Dorairaj, Mattias Ekstedt, Mohamed El‐Kassas, Osama Mohamed Elsanousi, Gamal Esmat, Jian‐Gao Fan, Nathalie J. Farpour‐Lambert, Robert Flisiak, Yasser Fouad, Michael Fuchs, Rino Alvani Gani, Lynn H. Gerber, Hasmik Ghazinyan, Liana Gheorghe, George Boon‐Bee Goh, Henning Grønbæk, Aghayeva Gulnara, Saeed Hamid, Vanessa Hebditch ほか 121 名 - Nature Reviews Gastroenterology & Hepatology 2021 被引用: 736

  2. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Volker Keim, Johannes Wiegand - Journal of Hepatology 2016 被引用: 1,246

  3. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Won Kim, Myoung Seok Lee, Johannes Wiegand, Thomas Karlas, Yusuf Yılmaz, Guruprasad P. Aithal, Naaventhan Palaniyappan, Christophe Cassinotto, Sandeep Aggarwal, Harshit Garg, Geraldine Ooi, Atsushi Nakajima, Masato Yoneda, Marianne Ziol, Nathalie Barget, Andreas Geier, Theresa Tuthill, M. Julia Brosnan, Quentin M. Anstee, Stefan Neubauer, Stephen A. Harrison, Patrick M. Bossuyt, Michael Pavlides - Gut 2021 被引用: 485

  4. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ziv Ben‐Ari, Fernando Bessone, Mia J. Biondi, Abdul Rahman Bizri, Carlos Eduardo Brandão‐Mello, Krestina Brigida, Kimberly Brown, Robert S. Brown, Philip Bruggmann, Maurizia Rossana Brunetto, Dana Busschots, Marı́a Buti, Maia Butsashvili, Joaquín Cabezas, Chungman Chae, Viktorija Chaloska Ivanova, Henry Lik‐Yuen Chan, Hugo Cheinquer, Kent Jason G. Cheng, Myeong-Eun Cheon, Cheng‐Hung Chien, Rong‐Nan Chien, Gourdas Choudhuri, Peer Brehm Christensen, Wan‐Long Chuang, Vladimir Chulanov, Laura Cisneros, B. Coco, Fernando A Contreras, Markus Cornberg, Matthew Cramp, Javier Crespo, Fuqiang Cui, Chris Cunningham, Lucy Dagher Abou, Olav Dalgård, Doan Y Dao, Victor de Lédinghen, Moutaz Derbala, Keshab Deuba, Karan Dhindsa, Samsuridjal Djauzi, Sylvia Dražilová, Ann‐Sofi Duberg, Mohammed Elbadri, Manal H. El‐Sayed, Gamal Esmat, Chris Estes, Sameera Ezzat, Martti Färkkilâ, Laurent Ferradini, Maria Lúcia Gomes Ferraz, Paulo Roberto Abrão Ferreira, Tajana Filipec Kanižaj, Robert Flisiak, Soňa Fraňková, James Fung, Amiran Gamkrelidze, Edward Gane, Virginia Garcia, Javier García‐Samaniego, Manik Gemilyan, Jordan Genov, Liliana Gheorghe, Pierre M. Gholam, Adrian Goldis, Magnús Gottfreðsson, Richard T. Gray, Jason Grebely, Michael Gschwantler ほか 158 名 - ˜The œLancet. Gastroenterology & hepatology 2022 被引用: 653

  5. Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kevin Kim‐Jun Teh, Carmen Lara‐Romero, Amon Asgharpour, Sara Mahgoub, Mandy Sau-Wai Chan, Clémence M. Canivet, Manuel Romero‐Gómez, Seung Up Kim, Vincent Wai‐Sun Wong, VCTE-Prognosis Study Group - JAMA 2024 被引用: 201

  6. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Amarsanaa Jazag, Motswedi Anderson, Monique Andersson, Paige Armstrong, Tarik Asselah, Kostas Athanasakis, Oidov Baatarkhuu, Ziv Ben‐Ari, Aïcha Bensalem, Fernando Bessone, Mia Biondi, Abdul Rahman Bizri, Sarah Blach, Wornei Silva Miranda Braga, Carlos Eduardo Brandão‐Mello, Carol Brosgart, Kimberly Brown, Robert Brown, Jr, Philip Bruggmann, Maurizia Brunetto, Maria Buti, Joaquin Cabezas, Teresa Casanovas, Chungman Chae, Henry Lik Yuen Chan, Hugo Cheinquer, Pei-Jer Chen, Kent Jason Cheng, Myeong-Eun Cheon, Cheng-Hung Chien, Gourdas Choudhuri, Peer Brehm Christensen, Wan-Long Chuang, Vladimir Chulanov, Laura Cisneros, Carla Coffin, Fernando Contreras, Nicola Coppola, Markus Cornberg, Benjamin Cowie, Matthew Cramp, Antonio Craxi, Javier Crespo, Fuqiang Cui, Chris Cunningham, Olav Dalgard, Robert De Knegt, Victor De Ledinghen, Gregory Dore, Sylvia Drazilova, Ann-Sofi Duberg, Steve Egeonu, Mohammed Elbadri, Mohamed El-Kassas, Manal El-Sayed, Chris Estes, Ohad Etzion, Elmobashar Farag, Laurent Ferradini, Paulo Ferreira, Robert Flisiak, Xavier Forns, Sona Frankova, James Fung, Edward Gane, Virginia Garcia, Javier García-Samaniego, Manik Gemilyan, Jordan Genov, Liliana Gheorghe ほか 169 名 - ˜The œLancet. Gastroenterology & hepatology 2023 被引用: 404

  7. Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anja Geerts, Christophe Moreno, Ulrich Beuers, Peter R. Galle, U. Spengler, Elisabetta Bugianesi, Antonio Craxı̀, M. Angélico, Silvia Fargion, M Voiculescu, Liliana Gheorghe, Liliana Preoțescu, Juan Caballería, Raúl J. Andrade, Javier Crespo, J.L. Callera, Aftab Ala, Guruprasad P. Aithal, George Abouda, Velimir A. Luketic, Mao-Yu Huang, Stuart C. Gordon, Paul J. Pockros, Fred Poordad, Nathan J. Shores, Martin Moehlen, Kiran Bambha, Virginia Clark, Sanjaya K. Satapathy, Samir Parekh, R.K. Reddy, Muhammad Y. Sheikh, Gyöngyi Szabó, John M. Vierling, Timothy E. Foster, Guillermo E. Umpierrez, Chih‐Jen Chang, Terry Box, Juan F. Gallegos‐Orozco - Gastroenterology 2016 被引用: 1,014

  8. Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hannes Hagström, Camilla Akbari, Masashi Hirooka, Wah‐Kheong Chan, Sanjiv Mahadeva, Ruveena Bhavani Rajaram, Ming‐Hua Zheng, Jacob George, Mohammed Eslam, Salvatore Petta, Grazia Pennisi, Mauro Viganò, Sofia Ridolfo, Guruprasad P. Aithal, Naaventhan Palaniyappan, Dae Ho Lee, Mattias Ekstedt, Patrik Nasr, Christophe Cassinotto, Victor de Lédinghen, Annalisa Berzigotti, Yuly P. Mendoza, Mazen Noureddin, Emily Truong, Céline Fournier‐Poizat, Andreas Geier, Miljen Martić, Theresa Tuthill, Quentin M. Anstee, Stephen A. Harrison, Patrick M. Bossuyt, Michael Pavlides, Quentin M. Anstee, Ann K. Daly, Olivier Govaere, Simon Cockell, Dina Tiniakos, Pierre Bédossa, Alastair D. Burt, Fiona Oakley, Heather J. Cordell, Christopher P. Day, Kristy Wonders, Paolo Missier, Matthew McTeer, Luke Vale, Yemi Oluboyede, Matt Breckons, Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Max Nieuwdorp, Adriaan G. Holleboom, Joanne Verheij, Vlad Ratziu, Karine Clément, Rafael Patiño‐Navarrete, Raluca Pais, Valérie Paradis, Detlef Schuppan, Jörn M. Schattenberg, Rambabu Surabattula, Sudha Rani Myneni, Beate K. Straub, Toni Vidal-Puig, Michèle Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas ほか 130 名 - ˜The œLancet. Gastroenterology & hepatology 2023 被引用: 187

  9. Noninvasive biomarkers in NAFLD and NASH — current progress and future promise

    著者: , , , , - Nature Reviews Gastroenterology & Hepatology 2018 被引用: 620

  10. A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Farid-Hakeem Admane, Tabassome Simon, Raoul Poupon - New England Journal of Medicine 2018 被引用: 611

  11. Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2022 被引用: 199

  12. Diagnosis of Fibrosis and Cirrhosis Using Liver Stiffness Measurement in Nonalcoholic Fatty Liver Disease

    著者: , , , , , , , , , , , - Hepatology 2009 被引用: 1,301

  13. Determination of reliability criteria for liver stiffness evaluation by transient elastography

    著者: , , , , , , , , , , - Hepatology 2012 被引用: 647

  14. Controlled Attenuation Parameter (CAP): A Novel VCTE™ Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes

    著者: , , , , , , , - Ultrasound in Medicine & Biology 2010 被引用: 860

  15. Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver Disease

    著者: , , , , , , , , , , , , , , , , , , , , - Clinical Gastroenterology and Hepatology 2020 被引用: 185

  16. Confirmatory biomarker diagnostic studies are not needed when transitioning from NAFLD to MASLD

    著者: , , , , , - Journal of Hepatology 2023 被引用: 105

  17. EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version)

    著者: , , , , , , , , , , , , , , , , , , , - Ultraschall in der Medizin - European Journal of Ultrasound 2017 被引用: 1,004

  18. Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Johannes Wiegand, Thomas Karlas - ˜The œLancet. Gastroenterology & hepatology 2021 被引用: 256

  19. Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2020 被引用: 207

  20. Lean individuals with NAFLD have more severe liver disease and poorer clinical outcomes (NASH-CO Study)

    著者: , , , , , , , , , - Hepatology 2023 被引用: 108

  21. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xavier Causse, Claire Geist, Anne Minello, Isabelle Rosa, Moana Gelu‐Siméon, Isabelle Portal, F. Raffi, Marc Bourlière, Stanislas Pol - The Lancet 2019 被引用: 631

  22. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Abdullah M. Assiri, Oidov Baatarkhuu, Abate Bane, Ziv Ben‐Ari, Colm Bergin, Fernando Bessone, Florian Bihl, Abdul Rahman Bizri, Martin Blachier, Antonio Javier Blasco, Carlos Eduardo Brandão‐Mello, Philip Bruggmann, Cheryl Brunton, Filipe Calinas, Henry Lik‐Yuen Chan, Asad Chaudhry, Hugo Cheinquer, Chien‐Jen Chen, Rong‐Nan Chien, Moon Seok Choi, Peer Brehm Christensen, Wan‐Long Chuang, Vladimir Chulanov, Laura Cisneros, Mette Rye Clausen, Matthew Cramp, Antonio Craxı̀, Esther A. Croes, Olav Dalgård, Jorge Daruich, Victor de Lédinghen, Gregory J. Dore, Manal H. El‐Sayed, Gül Ergör, Gamal Esmat, Chris Estes, Karolin Falconer, Elmoubasher Farag, Maria Lúcia Gomes Ferraz, Paulo Roberto Abrão Ferreira, Robert Flisiak, Soňa Fraňková, Ivane Gamkrelidze, Ed Gane, Javier García‐Samaniego, Amir Ghafoor Khan, Ilias Gountas, Adrian Goldis, Magnús Gottfreðsson, Jason Grebely, Michael Gschwantler, Mário Guimarães Pessôa, J. Gunter, Behzad Hajarizadeh, O. Hajelssedig, Saeed Hamid, Waseem Hamoudi, Angelos Hatzakis, Sayed Himatt, Harald Hofer, Irena Hrstić, Yee-Tak Hui, Béla Hunyady, Ramazan Idılman, Wasim Jafri, Rohani Jahis, Naveed Z. Janjua, Peter Jarčuška, Agita Jēruma, Jón G. Jónasson ほか 122 名 - ˜The œLancet. Gastroenterology & hepatology 2016 被引用: 2,032

  23. Pitfalls of Liver Stiffness Measurement: A 5-Year Prospective Study of 13,369 Examinations

    著者: , , , , , , , - Hepatology 2009 被引用: 1,151

  24. Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Clinical Gastroenterology and Hepatology 2018 被引用: 167